🔎 Trials Near Me

Domov › Bolezen presadka proti gostitelju › New Jersey

Klinične študije za Bolezen presadka proti gostitelju v New Jersey

4 študij za Bolezen presadka proti gostitelju išče udeležence na lokacijah v New Jersey.

Mesta v New Jersey

Uradno besedilo študije (angleško)

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT07359859

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT07216443

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT07006506

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

  • Memorial Sloan Kettering at Basking Ridge (Consent only), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent only), Middletown
  • Memorial Sloan Kettering Cancer Center @ Bergen (Consent only), Montvale
Vključevanje udeležencevFaza 2
Starost 4 in več · Vsi spoli · Posodobljeno 22. maj 2026 · NCT05675930

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.